XTL BIOPHARMACEUTICALS LTD. Revenue
XTL BIOPHARMACEUTICALS LTD. (XTLB) reported Revenue of $451.00 thousand for the 12-month period ending 2024-12-31, per its 20-F filed 2025-04-30.
Financial Statements › Income Statement › Other Income
ifrs-full:Revenue · last filed 2025-04-30
| Period end | Revenue 12 month |
|---|---|
| 2024-12-31 | $451.00K 20-F · filed 2025-04-30 |